ABL Bio Inc. announced April 7 that it sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier (BBB) penetrating ...

Amid the current market turmoil, it is worth remembering that the pharmaceutical industry must continue its normal business of ensuring that it has products to sell in 10 years, with GSK (GSK) signing ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc (“GSK” or “the Company”) (NYSE: GSK) for violations of ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier. ABL Bio has ...

LOS ANGELES, April 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company ...

Dr Jules Bayliss, a medical director at vaccine manufacturer CSL Seqirus, said the last time there were this many influenza cases early in the year was 2020 when Australia closed its international ...

CSL Seqirus in Melbourne's Parkville produces essential products for Australia, including antivenoms and the Q fever vaccine, while its Tullamarine facility, set to be operational in 2026 ...

Jules Bayliss, medical director for vaccines and biosecurity at CSL Seqirus, said Australia was seeing the highest numbers of influenza infections ever seen outside of the traditional flu season.

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period ...

The NRT market is currently dominated by large, multibillion-dollar pharmaceutical companies, like Johnson & Johnson, which makes the Nicorette brand of products, the GlaxoSmithKline spinoff ...

British drugs giant GSK is launching a ground-breaking investigation that could save millions of Britons from developing dementia, The Mail on Sunday can reveal. The trailblazing study will use ...